Nicolas Hégerlé

807 total citations
12 papers, 464 citations indexed

About

Nicolas Hégerlé is a scholar working on Microbiology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Nicolas Hégerlé has authored 12 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Microbiology, 9 papers in Epidemiology and 2 papers in Infectious Diseases. Recurrent topics in Nicolas Hégerlé's work include Bacterial Infections and Vaccines (9 papers), Infective Endocarditis Diagnosis and Management (7 papers) and Pneumonia and Respiratory Infections (5 papers). Nicolas Hégerlé is often cited by papers focused on Bacterial Infections and Vaccines (9 papers), Infective Endocarditis Diagnosis and Management (7 papers) and Pneumonia and Respiratory Infections (5 papers). Nicolas Hégerlé collaborates with scholars based in France, United States and Japan. Nicolas Hégerlé's co-authors include Nicole Guiso, Gregory J. Dore, Elisabeth Njamkepo, A. Paris, Sophie Guillot, Delphine Brun, Raphael Simon, Sharon M. Tennant, Valérie Bouchez and Francesco Strati and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Microbiology.

In The Last Decade

Nicolas Hégerlé

12 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicolas Hégerlé France 12 321 306 94 87 59 12 464
Matías Fingermann Argentina 8 269 0.8× 224 0.7× 62 0.7× 30 0.3× 68 1.2× 18 356
Margaret C. Bash United States 16 528 1.6× 288 0.9× 84 0.9× 50 0.6× 131 2.2× 33 695
Francesco Renzi Belgium 13 133 0.4× 145 0.5× 41 0.4× 28 0.3× 124 2.1× 26 389
Tonia Zangari United States 12 100 0.3× 210 0.7× 140 1.5× 143 1.6× 47 0.8× 15 418
Feroze Ganaie United States 13 237 0.7× 498 1.6× 86 0.9× 35 0.4× 66 1.1× 36 629
Fabrice Godfroid Belgium 16 215 0.7× 390 1.3× 35 0.4× 122 1.4× 84 1.4× 20 637
Karina Hentrich Sweden 9 74 0.2× 186 0.6× 46 0.5× 31 0.4× 150 2.5× 10 393
Dorothea M. C. Hill United Kingdom 9 345 1.1× 300 1.0× 26 0.3× 23 0.3× 124 2.1× 9 461
LaDonna C. Carlson United States 8 118 0.4× 309 1.0× 199 2.1× 58 0.7× 99 1.7× 9 476
Antonia C. Perez United States 9 120 0.4× 181 0.6× 43 0.5× 28 0.3× 109 1.8× 11 346

Countries citing papers authored by Nicolas Hégerlé

Since Specialization
Citations

This map shows the geographic impact of Nicolas Hégerlé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Hégerlé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Hégerlé more than expected).

Fields of papers citing papers by Nicolas Hégerlé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Hégerlé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Hégerlé. The network helps show where Nicolas Hégerlé may publish in the future.

Co-authorship network of co-authors of Nicolas Hégerlé

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Hégerlé. A scholar is included among the top collaborators of Nicolas Hégerlé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Hégerlé. Nicolas Hégerlé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Hégerlé, Nicolas, Myeongjin Choi, James L. Sinclair, et al.. (2018). Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa. PLoS ONE. 13(9). e0203143–e0203143. 71 indexed citations
2.
Lillehoj, Erik P., Wei Guang, Sang Won Hyun, et al.. (2018). Neuraminidase 1–mediated desialylation of the mucin 1 ectodomain releases a decoy receptor that protects against Pseudomonas aeruginosa lung infection. Journal of Biological Chemistry. 294(2). 662–678. 19 indexed citations
4.
Yang, Mingjun, Girish Ramachandran, Surekha Shridhar, et al.. (2017). Development of a glycoconjugate vaccine to prevent invasive Salmonella Typhimurium infections in sub-Saharan Africa. PLoS neglected tropical diseases. 11(4). e0005493–e0005493. 40 indexed citations
5.
Bouchez, Valérie, Nicolas Hégerlé, Francesco Strati, Elisabeth Njamkepo, & Nicole Guiso. (2015). New Data on Vaccine Antigen Deficient Bordetella pertussis Isolates. Vaccines. 3(3). 751–770. 45 indexed citations
6.
Guiso, Nicole & Nicolas Hégerlé. (2014). OtherBordetellas, lessons for and from pertussis vaccines. Expert Review of Vaccines. 13(9). 1125–1133. 21 indexed citations
7.
Hégerlé, Nicolas & Nicole Guiso. (2014). Bordetella pertussisand pertactin-deficient clinical isolates: lessons for pertussis vaccines. Expert Review of Vaccines. 13(9). 1135–1146. 43 indexed citations
8.
Hégerlé, Nicolas, Gregory J. Dore, & Nicole Guiso. (2014). Pertactin deficient Bordetella pertussis present a better fitness in mice immunized with an acellular pertussis vaccine. Vaccine. 32(49). 6597–6600. 62 indexed citations
11.
Hégerlé, Nicolas & Nicole Guiso. (2013). Epidemiology of Whooping Cough & Typing of Bordetella Pertussis. Future Microbiology. 8(11). 1391–1403. 28 indexed citations
12.
Hégerlé, Nicolas, A. Paris, Delphine Brun, et al.. (2012). Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin. Clinical Microbiology and Infection. 18(9). E340–E346. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026